|
|||||
![]() |
|
Regional banking company Peoples Bancorp (NASDAQ:PEBO) met Wall Street’s revenue expectations in Q1 CY2025, but sales were flat year on year at $113 million. Its non-GAAP profit of $0.70 per share was 4.4% below analysts’ consensus estimates.
Is now the time to buy PEBO? Find out in our full research report (it’s free).
Peoples Bancorp’s first quarter results were met with a positive market response, as management pointed to stable loan growth, improvements in credit quality, and expanding core deposit balances despite a challenging operating environment. CEO Tyler Wilcox emphasized annualized loan growth above 4%, core deposit growth of over 3%, and reductions in both nonperforming assets and criticized loans as key drivers. The bank’s ability to reduce higher-cost brokered deposits contributed to a healthier funding mix, while fee-based income showed modest gains. Management cited one-time compensation and health expense items as weighing on profitability this quarter, with CFO Kathryn Bailey noting, “These expenses totaled $2 million for the first quarter.”
Looking ahead, Peoples Bancorp’s outlook centers on maintaining operating leverage and disciplined cost control, even as macroeconomic uncertainty and potential interest rate changes persist. The company expects full-year net interest margin to remain in the 4% to 4.2% range and anticipates mid-single-digit growth in fee-based income, assuming rate cuts from the Federal Reserve later in the year. Wilcox highlighted that the bank’s asset sensitivity is now largely neutral, allowing for resilience against rate volatility, and added, “We’re positioned so the declines in interest rates have a minor impact to our net interest margin.” Continued attention to credit quality and prudent loan growth remain strategic priorities.
Management attributed the steady quarter to strong loan production, improved asset quality, and proactive deposit management, while acknowledging elevated expenses and modest fee income growth.
Management’s forward outlook is shaped by expectations of stable margins, prudent loan growth, and ongoing cost discipline amid an uncertain rate and macroeconomic backdrop.
Our analyst team will closely watch (1) whether loan and deposit growth remains resilient as macroeconomic and tariff uncertainties persist, (2) signs of further improvement in credit quality, particularly within the leasing portfolio, and (3) progress toward stabilizing noninterest expenses and achieving targeted efficiency ratios. Execution on cost management and fee income diversification will also be key areas of focus.
Peoples Bancorp currently trades at $29.61, up from $27.54 just before the earnings. In the wake of this quarter, is it a buy or sell? Find out in our full research report (it’s free).
The market surged in 2024 and reached record highs after Donald Trump’s presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025.
While the crowd speculates what might happen next, we’re homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver’s seat and build a durable portfolio by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
Sep-09 | |
Jul-23 | |
Jul-23 | |
Jul-22 | |
Jul-22 | |
Jul-22 | |
Jul-22 | |
Jul-22 | |
Jul-22 | |
Jul-22 | |
Jul-21 | |
Jul-20 | |
Jun-29 | |
Jun-26 | |
Jun-23 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite